Your session is about to expire
← Back to Search
Piperacillin/Tazobactam vs Meropenem for Bacterial Blood Infections (PETERPEN Trial)
PETERPEN Trial Summary
This trial is testing whether piperacillin-tazobactam is as good as meropenem for treating blood-stream infections caused by bacteria that are resistant to cephalosporins.
PETERPEN Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowPETERPEN Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.PETERPEN Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- The infection I have is resistant to certain antibiotics but can be treated with PTZ and meropenem.I have a blood infection caused by E. coli or Klebsiella, possibly with other non-harmful bacteria.It's been over 72 hours since my first blood culture was taken.I have had very low blood pressure or needed strong medicine to increase it recently.I am 18 years old or older.I have a blood infection, whether caught at home or in the hospital.I have a new blood infection caused by E. coli or Klebsiella.I have an ongoing infection and haven't finished my antibiotics.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the sample size of this medical experiment?
"Affirmative. As per the information hosted on clinicaltrials.gov, this research is actively recruiting participants; it was launched May 1st 2019 and has been amended for the last time as of July 25th 2022. The study necessitates 1084 patients across a single site."
To what extent can Piperacillin/tazobactam be relied upon for patient safety?
"Having already been approved, the safety of Piperacillin/tazobactam is rated highly and given a score of 3."
Is registration for this clinical trial currently available to patients?
"The information found on clinicaltrials.gov demonstrates that this trial is actively enrolling patients as of now. This programme was initially posted in May 2019 and revised most recently in July 2022."
Share this study with friends
Copy Link
Messenger